Series BHealthIndia · BengaluruJun 08, 2026

Immuneel Therapeutics raises $10.5M Series B (India, Jun 2026)

$10.5M
Rs 100 Crore
Browse investors in India →
Generated social card
Immuneel Therapeutics social card
Headline

Immuneel Secures Rs 100 Crore to Expand Cancer Therapies - Siliconindia

About

Immuneel Therapeutics is a cancer-focused biotech startup that develops cell and gene therapies designed to treat complex cancers. The company aims to make advanced immunotherapy treatments more accessible to patients in India and other emerging markets, with a focus on scaling manufacturing and advancing research.

Article summary

Immuneel Secures Rs 100 Crore to Expand Cancer Therapies  Siliconindia

Founder
Kiran Mazumdar-Shaw
Kiran Mazumdar-Shaw
Co-founder
Investors · 5
3 hidden
Singularity AMCLead
FUND
Rainmatter by Zerodha
FUND
Sign up free · see all 5 investors
Related rounds
Jun 28, 2026SuperLiving$7.0MSeries AIndia
Jun 27, 2026$1.08B—India
Jun 27, 2026AllHome$21.0MSeries BIndia
Jun 27, 2026Supermemory$3.0M—India
Immuneel Therapeutics raises $10.5M Series B (India, June 2026) | Datapile